TNBI
Tanke Biosciences CorpCompany Information
- Company Name
- Tanke Biosciences Corp
- CIK
- CIK0001452011
- Category
- N/A
- Ticker: Exchange
- TNBI: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 04 Manufacturing
- SIC
- 2040
- SIC Description
- Grain Mill Products
- Ticker
- TNBI
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2013-11-14
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- 16.67%
Balance Sheet
Values in millions ($)| Line item | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 5 | 5 | 6 | 6 | 11 | 10 | 8 | 8 | 10 | 11 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 2 | ||||||
| Inventory Net | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Due From Related Parties Current | - | - | - | - | - | - | 0 | 0 | 1 | 2 | ||||||
Assets Current | ||||||||||||||||
| Accounts And Other Receivables Net Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | - | - | ||||||
| Assets Current | 20 | 22 | 22 | 22 | 22 | 21 | 18 | 19 | 21 | 19 | ||||||
| Other Receivables | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | ||||||
| Prepaid Expense Current | - | - | - | - | 3 | 3 | 3 | - | - | - | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | ||||||
| Deferred Tax Assets Liabilities Net Current | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Deferred Tax Assets Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Property Plant And Equipment Net | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | ||||||
| Construction In Progress Gross | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Due From Related Parties Noncurrent | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Finite Lived Intangible Assets Net | 1 | 1 | 1 | - | - | - | - | - | - | - | ||||||
| Assets | 29 | 29 | 29 | 29 | 29 | 27 | 24 | 25 | 26 | 23 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | 5 | - | - | - | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 0 | ||||||
| Accrued Income Taxes Current | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||
| Liabilities Current | 12 | 13 | 12 | 12 | 11 | 10 | 9 | 4 | 5 | 3 | ||||||
| Due To Related Parties Current | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Customer Advances Current | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Convertible Debt Current | 8 | 8 | 8 | 7 | 7 | 6 | - | - | - | - | ||||||
| Long Term Debt Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | - | - | 4 | 6 | 4 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | 0 | 4 | - | - | ||||||
| Notes Payable Related Parties Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Deferred Revenue And Credits Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Noncurrent | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 1 | 1 | 1 | ||||||
| Liabilities | 13 | 14 | 13 | 13 | 12 | 12 | 9 | 9 | 12 | 8 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | - | - | - | - | - | - | 12 | 12 | - | - | ||||||
| Additional Paid In Capital | 12 | 12 | 12 | 12 | 12 | 12 | - | 12 | 12 | 12 | ||||||
| Retained Earnings Accumulated Deficit | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 1 | 2 | ||||||
| Statutory Accounting Practices Retained Earnings Not Available For Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Minority Interest | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | - | ||||||
Stockholders Equity | ||||||||||||||||
| Stockholders Equity | 16 | 16 | 15 | 16 | 17 | 16 | 15 | 16 | 14 | 15 | ||||||
| Liabilities And Stockholders Equity | 29 | 29 | 29 | 29 | 29 | 27 | 24 | 25 | 26 | 23 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | ||||||
| Shares Outstanding | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialTanke Biosciences Corp (TNBI) — SEC Financial Statements & Analysis
Tanke Biosciences Corp (TNBI) is a grain mill products company, incorporated in NV. Tanke Biosciences Corp trades on OTC as: TNBI. Tanke Biosciences Corp (TNBI)'s most recent SEC filing is a Form 10-Q for the period ended 2013-09-30, filed with the SEC on 2013-11-14. Based on that filing, Tanke Biosciences Corp carries a market cap of $2.66M, a P/E ratio of -1.62x, a P/B ratio of 0.17x, a P/S ratio of 0.12x, an enterprise value of $6.99M, and an EV/EBITDA multiple of 8.69x. On profitability, it posts a gross margin of 32.28%, an operating margin of -0.25%, a net margin of -7.16%, a Return on Equity (ROE) of -10.19%, a Return on Assets (ROA) of -5.70%, and a Return on Invested Capital (ROIC) of -0.29%. Per share, it reports EPS of $-0.12, diluted EPS of $0.04, free cash flow per share of $-0.46, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -33.40% year-over-year, net income growth of -407.89% year-over-year, and EPS growth of -407.89% year-over-year. On the balance sheet, it maintains a current ratio of 1.61x, a quick ratio of 1.48x, working capital of $7.46M, a debt-to-equity ratio of 0.83x, a debt ratio of 0.45, an interest coverage ratio of -0.08x, free cash flow of $-6.13M (TTM), and net debt of $4.33M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.66M
- P/E TTM
- -1.62x
- EPS TTM
- $-0.12
- P/B TTM
- 0.17x
- ROE TTM
- -10.19%
- ROA TTM
- -5.70%
- Debt To Equity
- 0.83x
- Free Cash Flow TTM
- $-6.13M
- Net Revenue TTM Growth 1Y
- -33.40%
Data as of 2013-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Tanke Biosciences Corp in?
Tanke Biosciences Corp (TNBI) operates in the Grain Mill Products industry.
What exchange does TNBI trade on?
Tanke Biosciences Corp (TNBI) trades on the OTC.
Where is Tanke Biosciences Corp incorporated?
Tanke Biosciences Corp is incorporated in NV.
When was Tanke Biosciences Corp (TNBI)'s most recent SEC filing?
Tanke Biosciences Corp (TNBI)'s most recent SEC filing is a Form 10-Q for the period ended 2013-09-30, filed with the SEC on 2013-11-14.
What is TNBI's market cap?
Tanke Biosciences Corp (TNBI) has a market capitalization of $2.66M as of 2013-09-30.
What is TNBI's EPS (earnings per share)?
Tanke Biosciences Corp (TNBI)'s trailing twelve month EPS is $-0.12 as of 2013-09-30.
What is TNBI's ROE (return on equity)?
Tanke Biosciences Corp (TNBI)'s trailing twelve month Return on Equity (ROE) is -10.19% as of 2013-09-30.
What is TNBI's ROA (return on assets)?
Tanke Biosciences Corp (TNBI)'s trailing twelve month Return on Assets (ROA) is -5.70% as of 2013-09-30.
What is TNBI's ROIC (return on invested capital)?
Tanke Biosciences Corp (TNBI)'s trailing twelve month Return on Invested Capital (ROIC) is -0.29% as of 2013-09-30.
What is TNBI's EV/EBITDA?
Tanke Biosciences Corp (TNBI)'s trailing twelve month EV/EBITDA is 8.69x as of 2013-09-30.